Editas Medicine, Inc. (EDIT) vs Senseonics Holdings, Inc. (SENS)
A side-by-side comparison of Editas Medicine, Inc. and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EDIT
Editas Medicine, Inc.
$2.80HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
SENS
Senseonics Holdings, Inc.
$9.89HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — EDIT vs SENS
growth of $100 · dividends reinvested · last 10yEDIT -79.3% (-14.6%/yr)SENS -86.3% (-18.0%/yr)EDIT compounded faster over this window
EDIT SENS
EDIT vs SENS: by the numbers
- •EDIT is the larger company ($430M vs $413M market cap).
- •Both run net losses; EDIT's is the smaller (-157.32% vs -225.34% net margin).
- •SENS grew revenue faster over the past five years (35.10% vs -10.34% CAGR).
Metrics side by side
Valuation
| Metric | EDIT | SENS |
|---|---|---|
| P/S ratio | 9.16 | 8.51 |
| P/B ratio | 4.09 | 4.58 |
Profitability
| Metric | EDIT | SENS |
|---|---|---|
| Gross margin | 100.00% | 44.71% |
| Operating margin | -245.15% | -193.83% |
| Net margin | -157.32% | -225.34% |
| ROE | -70.24% | -121.12% |
| ROIC | -48.61% | -71.22% |
Growth (annualized)
| Metric | EDIT | SENS |
|---|---|---|
| Revenue CAGR (5Y) | -10.34% | 35.10% |
| Total return CAGR (5Y) | -40.76% | -30.89% |
Frequently asked
- Which has grown faster, EDIT or SENS?
- Over the past five years, SENS grew revenue faster — EDIT at a -10.34% CAGR versus SENS at 35.10%.
- How have EDIT and SENS total returns compared?
- Over the past 10 years, EDIT delivered -15.75% and SENS delivered -18.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Editas Medicine ROESenseonics ROEEditas Medicine operating marginSenseonics operating marginEditas Medicine revenue growthSenseonics revenue growthEditas Medicine free cash flowSenseonics free cash flow
Editas Medicine & Senseonics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.